175 related articles for article (PubMed ID: 28987389)
1. Environmental tobacco smoke exposure and EGFR and ALK alterations in never smokers' lung cancer. Results from the LCRINS study.
Torres-Durán M; Ruano-Ravina A; Kelsey KT; Parente-Lamelas I; Leiro-Fernández V; Abdulkader I; Provencio M; Abal-Arca J; Castro-Añón O; Montero-Martínez C; Vidal-García I; Amenedo M; Golpe-Gómez A; Martínez C; Guzmán-Taveras R; Mejuto-Martí MJ; Fernández-Villar A; Barros-Dios JM
Cancer Lett; 2017 Dec; 411():130-135. PubMed ID: 28987389
[TBL] [Abstract][Full Text] [Related]
2. Association Between Environmental Tobacco Smoke Exposure and the Occurrence of EGFR Mutations and ALK Rearrangements in Never-smokers With Non-Small-cell Lung Cancer: Analyses From a Prospective Multinational ETS Registry.
Soo RA; Kubo A; Ando M; Kawaguchi T; Ahn MJ; Ou SI
Clin Lung Cancer; 2017 Sep; 18(5):535-542. PubMed ID: 28433570
[TBL] [Abstract][Full Text] [Related]
3. Impact of environmental tobacco smoke on the incidence of mutations in epidermal growth factor receptor gene in never-smoker patients with non-small-cell lung cancer.
Lee YJ; Cho BC; Jee SH; Moon JW; Kim SK; Chang J; Chung KY; Park IK; Choi SH; Kim JH
J Clin Oncol; 2010 Jan; 28(3):487-92. PubMed ID: 20008630
[TBL] [Abstract][Full Text] [Related]
4. Long exposure of environmental tobacco smoke associated with activating EGFR mutations in never-smokers with non-small cell lung cancer.
Kawaguchi T; Ando M; Kubo A; Takada M; Atagi S; Okishio K; Asami K; Matsumura A; Tsujino K; Ignatius OS; Sasaki H
Clin Cancer Res; 2011 Jan; 17(1):39-45. PubMed ID: 21059816
[TBL] [Abstract][Full Text] [Related]
5. p53 mutations and exposure to environmental tobacco smoke in a multicenter study on lung cancer.
Husgafvel-Pursiainen K; Boffetta P; Kannio A; Nyberg F; Pershagen G; Mukeria A; Constantinescu V; Fortes C; Benhamou S
Cancer Res; 2000 Jun; 60(11):2906-11. PubMed ID: 10850436
[TBL] [Abstract][Full Text] [Related]
6. Lung cancer mutation profile of EGFR, ALK, and KRAS: Meta-analysis and comparison of never and ever smokers.
Chapman AM; Sun KY; Ruestow P; Cowan DM; Madl AK
Lung Cancer; 2016 Dec; 102():122-134. PubMed ID: 27987580
[TBL] [Abstract][Full Text] [Related]
7. Residential radon, EGFR mutations and ALK alterations in never-smoking lung cancer cases.
Ruano-Ravina A; Torres-Durán M; Kelsey KT; Parente-Lamelas I; Leiro-Fernández V; Abdulkader I; Abal-Arca J; Montero-Martínez C; Vidal-García I; Amenedo M; Castro-Añón O; Golpe-Gómez A; González-Barcala J; Martínez C; Guzmán-Taveras R; Provencio M; Mejuto-Martí MJ; Fernández-Villar A; Barros-Dios JM
Eur Respir J; 2016 Nov; 48(5):1462-1470. PubMed ID: 27799390
[TBL] [Abstract][Full Text] [Related]
8. No impact of passive smoke on the somatic profile of lung cancers in never-smokers.
Couraud S; Debieuvre D; Moreau L; Dumont P; Margery J; Quoix E; Duvert B; Cellerin L; Baize N; Taviot B; Coudurier M; Cadranel J; Missy P; Morin F; Mornex JF; Zalcman G; Souquet PJ;
Eur Respir J; 2015 May; 45(5):1415-25. PubMed ID: 25745045
[TBL] [Abstract][Full Text] [Related]
9. Association between self-reported environmental tobacco smoke exposure and lung cancer: modification by GSTP1 polymorphism.
Miller DP; De Vivo I; Neuberg D; Wain JC; Lynch TJ; Su L; Christiani DC
Int J Cancer; 2003 May; 104(6):758-63. PubMed ID: 12640684
[TBL] [Abstract][Full Text] [Related]
10. Environmental tobacco smoke exposure in women with lung cancer.
de Andrade M; Ebbert JO; Wampfler JA; Miller DL; Marks RS; Croghan GA; Jatoi A; Finke EE; Sellers TA; Yang P
Lung Cancer; 2004 Feb; 43(2):127-34. PubMed ID: 14739032
[TBL] [Abstract][Full Text] [Related]
11. A Stratified Meta-Analysis of the Association between Exposure to Environmental Tobacco Smoke during Childhood and Adulthood and Urothelial Bladder Cancer Risk.
van Osch FHM; Jochems SHJ; Wesselius A; van Schooten FJ; Bryan RT; Zeegers MP
Int J Environ Res Public Health; 2018 Mar; 15(4):. PubMed ID: 29565277
[No Abstract] [Full Text] [Related]
12. Distinct clinical features and outcomes in never-smokers with nonsmall cell lung cancer who harbor EGFR or KRAS mutations or ALK rearrangement.
Kim HR; Shim HS; Chung JH; Lee YJ; Hong YK; Rha SY; Kim SH; Ha SJ; Kim SK; Chung KY; Soo R; Kim JH; Cho BC
Cancer; 2012 Feb; 118(3):729-39. PubMed ID: 21720997
[TBL] [Abstract][Full Text] [Related]
13. Environmental tobacco smoke and lung cancer in nonsmoking women. A multicenter study.
Fontham ET; Correa P; Reynolds P; Wu-Williams A; Buffler PA; Greenberg RS; Chen VW; Alterman T; Boyd P; Austin DF
JAMA; 1994 Jun; 271(22):1752-9. PubMed ID: 8196118
[TBL] [Abstract][Full Text] [Related]
14. Exposure misclassification bias in studies of environmental tobacco smoke and lung cancer.
Wu AH
Environ Health Perspect; 1999 Dec; 107 Suppl 6(Suppl 6):873-7. PubMed ID: 10592145
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic characteristics of EGFR, KRAS, and ALK alterations in 6,595 lung cancers.
Lee B; Lee T; Lee SH; Choi YL; Han J
Oncotarget; 2016 Apr; 7(17):23874-84. PubMed ID: 26992209
[TBL] [Abstract][Full Text] [Related]
16. Polygenic Risk Score, Environmental Tobacco Smoke, and Risk of Lung Adenocarcinoma in Never-Smoking Women in Taiwan.
Blechter B; Chien LH; Chen TY; Chang IS; Choudhury PP; Hsiao CF; Shu XO; Wong JYY; Chen KY; Chang GC; Tsai YH; Su WC; Huang MS; Chen YM; Chen CY; Hung HH; Hu JW; Shi J; Zheng W; Rositch AF; Chen CJ; Chatterjee N; Yang PC; Rothman N; Hsiung CA; Lan Q
JAMA Netw Open; 2023 Nov; 6(11):e2339254. PubMed ID: 37955902
[TBL] [Abstract][Full Text] [Related]
17. GSTM1, GSTT1 and GSTP1 polymorphisms, environmental tobacco smoke exposure and risk of lung cancer among never smokers: a population-based study.
Wenzlaff AS; Cote ML; Bock CH; Land SJ; Schwartz AG
Carcinogenesis; 2005 Feb; 26(2):395-401. PubMed ID: 15528218
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathologic characteristics and outcomes of patients with anaplastic lymphoma kinase-positive advanced pulmonary adenocarcinoma: suggestion for an effective screening strategy for these tumors.
Koh Y; Kim DW; Kim TM; Lee SH; Jeon YK; Chung DH; Kim YW; Heo DS; Kim WH; Bang YJ
J Thorac Oncol; 2011 May; 6(5):905-12. PubMed ID: 21358343
[TBL] [Abstract][Full Text] [Related]
19. Chronic Obstructive Pulmonary Disease-Related Non-Small-Cell Lung Cancer Exhibits a Low Prevalence of EGFR and ALK Driver Mutations.
Lim JU; Yeo CD; Rhee CK; Kim YH; Park CK; Kim JS; Kim JW; Lee SH; Kim SJ; Yoon HK; Kim TJ; Lee KY
PLoS One; 2015; 10(11):e0142306. PubMed ID: 26555338
[TBL] [Abstract][Full Text] [Related]
20. Lung cancers with concomitant EGFR mutations and ALK rearrangements: diverse responses to EGFR-TKI and crizotinib in relation to diverse receptors phosphorylation.
Yang JJ; Zhang XC; Su J; Xu CR; Zhou Q; Tian HX; Xie Z; Chen HJ; Huang YS; Jiang BY; Wang Z; Wang BC; Yang XN; Zhong WZ; Nie Q; Liao RQ; Mok TS; Wu YL
Clin Cancer Res; 2014 Mar; 20(5):1383-92. PubMed ID: 24443522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
